Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients. [electronic resource]
Producer: 20110210Description: 1035-8 p. digitalISSN:- 2040-2058
- Adult
- Aged
- Anti-HIV Agents -- administration & dosage
- Antiretroviral Therapy, Highly Active -- adverse effects
- Atazanavir Sulfate
- CD4 Lymphocyte Count
- Drug Interactions
- Female
- Follow-Up Studies
- HIV -- drug effects
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- administration & dosage
- Humans
- Lamivudine -- therapeutic use
- Male
- Middle Aged
- Oligopeptides -- administration & dosage
- Pyridines -- administration & dosage
- Pyrrolidinones -- administration & dosage
- Raltegravir Potassium
- Retrospective Studies
- Reverse Transcriptase Inhibitors -- therapeutic use
- Ritonavir -- therapeutic use
- Viral Load -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.